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Abstract
We sequenced the evolutionarily conserved genes 16S rRNA, atpD, tuf, and recA from Streptococcus pseudopneumoniae, Streptococcus
pneumoniae, Streptococcus mitis, and Streptococcus oralis. Phylogenetic analysis revealed that recA provided good resolution between these
species, including discrimination of the novel species S. pseudopneumoniae. By contrast, the more conserved 16S rRNA, tuf and atpD are
not sufﬁciently discriminatory. Therefore, recA sequences were used to develop a real-time PCR assay with a locked nucleic acid-medi-
ated TaqMan probe for the speciﬁc detection and identiﬁcation of S. pseudopneumoniae. The PCR assay showed excellent speciﬁcity and
a detection limit of <10 genome copies for the detection and identiﬁcation of S. pseudopneumoniae strains, which makes it a promising
tool for molecular identiﬁcation and epidemiological studies. In conclusion, this article describes for the ﬁrst time a PCR assay for the
speciﬁc identiﬁcation of S. pseudopneumoniae.
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Streptococcus pseudopneumoniae is a novel species related to
the mitis group of streptococci, which includes 15 species
[1]. Among these species, S. pseudopneumoniae is phenotypi-
cally and genetically close to Streptococcus pneumoniae,
Streptococcus mitis, and Streptococcus oralis [2,3]. All S. pseudo-
pneumoniae strains described to date have been isolated from
lower respiratory tract samples [2,4–7]. The clinical impor-
tance of this species is currently unknown [6,7]. However,
Keith et al. [7] observed that patients with S. pseudopneumo-
niae infection were more likely to have a history of chronic
obstructive pulmonary disease or exacerbation of chronic
obstructive pulmonary disease. Moreover, antibiotic-resistant
strains of S. pseudopneumoniae have already been described
[5,7–9].
Currently, S. pseudopneumoniae can be identiﬁed on the
basis of bile solubility and optochin tests. S. pseudopneumoniae
cells are not soluble in bile, and are resistant or intermediate
to optochin when incubated under an atmosphere supple-
mented with 5% CO2, but are susceptible to optochin when
incubated in air [2]. Various commercial phenotype-based
tests have been evaluated, but these tests fail to differentiate
S. pseudopneumoniae and S. pneumoniae [2]. PCR assays target-
ing 16S rRNA, pneumococcal surface adhesion (psaA), pneum-
olysin (ply), D-alanine:D-alanine ligase (ddl), glutamate
dehydrogenase (gdh), the b-subunit of RNA polymerase (rpoB)
and manganese-dependent superoxide dismutase (sodA) gene
sequences have been published as genetic methods for the
identiﬁcation of pneumococci. However, none of these molec-
ular tests can discriminate S. pseudopneumoniae from S. pneu-
moniae [2,4]. PCR assays based on the autolysin gene (lytA)
have shown that S. pneumoniae can be discriminated from
pneumococcus-like viridans group streptococci, including
S. pseudopneumoniae. However, the use of lytA as a molecular
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target does not enable S. pseudopneumoniae to be distin-
guished from other viridans streptococci [4,10].
The increasing number of newly identiﬁed or previously
unrecognized pathogens, the availability of new antimicrobial
agents and the evolution of bacterial resistance mechanisms
have contributed to changes in the epidemiology and treatment of
respiratory tract infections. The development of new diagnostic
tests for pathogen identiﬁcation and determination of resis-
tance proﬁles will certainly improve the selection of appropri-
ate antibiotic therapy for the treatment of lower respiratory
tract infections [11]. Consequently, it is important for the lab-
oratory to differentiate S. pneumoniae, S. pseudopneumoniae,
and the mitis group streptococci, notably S. mitis and S. oralis,
as identiﬁcation may inﬂuence diagnosis and treatment.
In this study, we analysed four conserved genes—16S
rRNA, atpD (encoding the F0F1 H
+-ATPase b-subunit), tuf
(encoding elongation factor Tu), and recA (encoding RecA, a
protein contributing to homologous recombination)—that
have already been used to reconstruct bacterial phylogeny
[13–16]. Their capacity for species discrimination was evalu-
ated. We also developed a real-time PCR assay for the
detection and identiﬁcation of S. pseudopneumoniae.
Materials and Methods
Strains
A complete list of strains used in this study is provided in
Table S1. All clinical strains, from the Centre de Recherche
en Infectiologie, were identiﬁed phenotypically with the Posi-
tive Breakpoint Combo 20 of the Microscan system (Dade
Behring, West Sacramento, CA, USA). Isolates were cultured
on sheep blood agar plates at 35C under a 5% CO2-
enriched atmosphere unless otherwise stated.
TABLE 1. Phenotypic test results
for Streptococcus pseudopneumoniae










S. pneumoniae ATCC 51916 S S S
S. pneumoniae ATCC 700673 S S S
S. pneumoniae CCRI-1393 S S S
S. pneumoniae CCRI-17887 S S S
S. pneumoniae CCRI-18437 S S S
S. pneumoniae CCRI-1396 S S S
S. pneumoniaee CCRI-8999 S S S
S. pneumoniaee CCRI-14740 S S S
S. pneumoniaee CCRI-14753 S S S
S. pneumoniaee CCRI-14763 S S S
S. pneumoniaee CCRI-15209 S S S
S. pneumoniaee CCRI-15786 S S S
S. pneumoniaee CCRI-17733 S S S
S. pneumoniaee CCRI-15796 S S S
S. pneumoniaee 578 S S I
S. pneumoniaee 1504 S S I
S. pneumoniaee 101/87 R R I
S. pseudopneumoniaef CCRI-8984 S R I
S. pseudopneumoniaef CCRI-14743 S R I
S. pseudopneumoniaef CCRI-18123 S R I
S. pseudopneumoniae CCUG 49455T S R I
S. pseudopneumoniae CCUG 50868 S R I
S. pseudopneumoniae CCUG 50869 S R I
S. pseudopneumoniae CCUG 50870 S R I
S. pseudopneumoniae 2482-91 S R I
S. pseudopneumoniae 2483-91 S R I
S. pseudopneumoniae 2497-91 S R I
S. pseudopneumoniae 2987-98 S R I
S. mitis ATCC 49456T R R I
S. mitis CCRI-1398 R R I
S. mitis CCRI-14944 R R I
S. mitis CCRI-14955 R R I
S. mitis CCRI-15019 R R I
S. mitis CCRI-15034 R R I
S. mitis CCRI-15059 R R I
S. mitis CCRI-17399 R R I
S. oralis ATCC 35037T R R I
S. oralis ATCC 10557 R R I
S. oralis CCRI-15017 R R I
S. oralis CCRI-15027 R R I
aIdentiﬁcation by optochin test, bile solubility, and genotyping.
b T indicates type strain.
cOptochin test: S, susceptible; R, resistant.
dBile solubility: S, soluble; I, insoluble.
eS. pneumoniae atypical.
fFormerly S. pneumoniae.
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Phenotypic identiﬁcation
Phenotypes of all S. pseudopneumoniae isolates, and some iso-
lates of S. pneumoniae, S. mitis, and S. oralis, were conﬁrmed
by optochin sensitivity and bile solubility as previously
described [2] (Table 1).
Sequencing
PCR ampliﬁcations were performed with crude DNA
extracts, using the primers described in Table 2. Crude
DNA extracts from bacteria were prepared by using the BD
GeneOhm Lysis Kit (BD Diagnostics-GeneOhm, Quebec,
QC, Canada), as recommended by the manufacturer. PCR
ampliﬁcations, sequencing and phylogenetic analysis were
performed as previously described [14]. The GenBank acces-
sion numbers of 16S rRNA, atpD, tuf, and recA sequences
are shown in Figs 1 and 2, and Fig. S1.
Real-time PCR assay
A 135-bp fragment of recA gene was ampliﬁed by use of the
following reaction mixture: 0.05 U/lL Taq DNA polymerase
(Promega, Madison, WI, USA) combined with the TaqStart
Antibody (Clontech Takara Bio, Mountain View, CA, USA),
200 lM dNTP (Amersham Biosciences, Piscataway, NJ, USA),
10 mM Tris-HCl (pH 9.1), 50 mM KCl, 3.3 mg/mL bovine
serum albumin (Sigma-Aldrich Canada, Oakville, Ontario,
Canada), 0.1% Triton, 2.5 mM MgCl2, 0.6 lM primers, and
0.2 lM probe (Table 2). One microlitre of sample DNA was
added to the reaction mixture to give a ﬁnal 25-lL reaction
volume. DNA was ampliﬁed with a Rotor-Gene 3000 (Corb-
ett Research, Bath, UK) by using the following cycling parame-
ters: an initial denaturing step at 94C for 3 min, followed by
45 cycles of a denaturing step at 95C for 5 s, an annealing
step at 57C for 15 s, and an extension step at 72C for 30 s.
Data acquisition and analysis for the real-time PCR assay were
performed with the Rotor-Gene data analysis software
(Corbett Research supporting programs).
Puriﬁcation of genomic DNA
Colonies of pure cultures were treated with the BD Gene-
Ohm Lysis Kit (BD Diagnostics-GeneOhm), as recommended
by the manufacturer. The crude DNA extracts were then
treated with RNase (Qiagen, Mississauga, Ontario, Canada)
for 15 min at 55C. Genomic DNA from the crude extracts
was puriﬁed with the MagneSil KF Genomic System
(Promega) on a KingFisher instrument (ThermoLabsystem,
Dreieich, Germany).
Speciﬁcity and sensitivity of the real-time PCR
Speciﬁcity tests were performed with 1 ng/lL puriﬁed genomic
DNA from 11 S pseudopneumoniae isolates, 12 S. pneumoniae
isolates, six S. mitis isolates, and four S. oralis isolates (Table 1).
Four S. pseudopneumoniae strains (CCUG 49455T, CCUG
50869, CCUG 50868, and CCRI-8984) were used to deter-
mine the sensitivity of the real-time PCR assay. Serial ten-fold
dilutions (ranging from 105 to 10 copies) of puriﬁed genomic
DNA from these strains were used for sensitivity tests.
Results and Discussion
Evaluation of 16S rRNA, atpD, tuf, and recA gene for
S. pseudopneumoniae identiﬁcation
Initially, the four conserved genes were sequenced from 22
type and reference strains of S. pseudopneumoniae (n = 4),
TABLE 2. Primers and probe used for PCR ampliﬁcation/sequencing and real-time PCR






recA RStrGseq81 GAAAWWIATYGARAAAGAITTTGGTAA 54 852
RStrGseq937 TTYTCAGAWCCTTGICCAATYTTYTC
tuf UTseq271 AAYATGATIACIGGIGCIGCICARATGGA 57 881
UTseq1138 CCIACIGTICKICCRCCYTCRCG
atpD UAseq27b RTIRYIGGICCIGTIRTIGAYGT 54 902
UAseq883 TCRTCIGCIGGIACRTAIAYIGCYTG






recA RSpneSpse677 GTGCTITGAAATTCTATGCTTC 57 135
RSpneSpse790 GTGGAGCTACCTTATTTTTTAC
RSpse-TL1-B1c,d,e TET-TGGTAACACACAAATTAAG-BHQ1
aI, inosine; Y, C or T; R, A or G; K, G or T; M, A or C; W, A or T.
bInternal primers used for sequencing only.
cBold and underlined nucleotides represent LNA residues.
dTET, 6-tetracholoroﬂuorescein.
eBHQ1, black hole quencher.
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S. pneumoniae (n = 8), S. mitis (n = 5), and S. oralis (n = 5).
The sequences were analysed, and phylogenetic trees were
constructed for each gene to discriminate S. pseudopneumo-
niae at the species level. The tree topologies obtained with
the neighbour-joining method were evaluated and conﬁrmed
by maximum-parsimony analysis (data not shown). Among
the S. pneumoniae strains used, three were considered to be
‘atypical’ S. pneumoniae strains (101/87, 578, and 1504, origi-
nally characterized by Diaz et al. [3]). The ‘atypical’ character
of S. pneumoniae strains is deﬁned as aberrant reactions to
optochin susceptibility and/or deoxycholate (bile) solubility.
Atypical pneumococcal isolates are also genetically distinct
from, although closely related to, typical pneumococci.
Indeed, Whatmore et al. [12] described strain 101/87 as the
prototype of atypical S. pneumoniae.
16S rDNA sequencing is well established as a standard
method for the identiﬁcation of bacterial species [17,18]. To
verify its capacity for discrimination of S. pseudopneumoniae,
sequences covering a 1471-bp segment of 16S rDNA from
the streptococcal strains were analysed. The 16S rDNA
sequences showed a high degree of homology within the
members of the mitis group, and minor differences in nucle-
otide sequences (£0.5%) between S. pseudopneumoniae and
S. pneumoniae. The 16S rRNA-based tree also revealed poor
resolution between S. pseudopneumoniae and S. pneumoniae
species (Fig. 1a). Moreover, the S. pseudopneumoniae strain
cluster was not well supported by the bootstrap value at the
node (63%). These results are in agreement with the results
previously described by Arbique et al. [2]. The high degree
of identity of 16S rDNA sequences between S. pseudopneu-
moniae and S. pneumoniae precluded distinction between
these species. Although sequencing of 16S r2DNA repre-
sents an excellent tool for the identiﬁcation of most organ-
isms, it often has insufﬁcient discriminatory power to
distinguish closely related species, such as members of the
mitis group of streptococci [2].
Use of atpD gene has previously been described for the
identiﬁcation of Enterobacteriaceae [14]. In the present study,
analysis of a 787-bp segment of atpD did not permit discrimi-
nation of S. pseudopneumoniae from S. pneumoniae and
S. mitis. The atpD-based tree revealed a main cluster formed
by typical S. pneumoniae strains, whereas it did not show a
 S. pneumoniae ATCC 700675 EU156774
 S. pneumoniae ATCC 700671 GU326246
 S. pneumoniae ATCC 700673 GU326247
 S. pneumoniae ATCC 51916 GU326245
T S. pneumoniae ATCC 33400  GU326244
 S. pseudopneumoniae CCUG 50870 EU156788
 CCUG 50869 EU156787S. pseudopneumoniae
 CCUG 50868 EU156786S. pseudopneumoniae
TS. pseudopneumoniae CCUG 49455  EU 156785
T S. mitis ATCC 49456  EU156760
 CCRI-15020 EU156763S. mitis
 CCRI-1398 EU156761S. mitis
 S. pneumoniae 101/87 GU326241
 S. pneumoniae 578 GU326243
 S. oralis CCRI-15027 EU156770
 CCRI-14955 EU156762S. mitis
 S. pneumoniae 1504 GU326242
 CCRI-15034 EU156764S. mitis
S. oralis CCRI-15017 EU156769
ATCC 10557 GU26239S. oralis 
TATC 35037  EU156768S. oralis
ATCC 9811 GU326240S. oralis







 S. pneumoniae ATCC 700675 EU156890
ATCC 51916 GU326254S. pneumoniae
ATCC 700673 GU326256S. pneumoniae
S. pneumoniae ATCC 700671 GU326255
TATCC 33400  GU326253S. pneumoniae
 S. pseudopneumoniae CCUG 50869 EU156903
T CCUG 49455  EU156901S. pseudopneumoniae
 CCUG 50870 EU156904S. pseudopneumoniae
 S. pneumoniae 578 GU326252
 S. mitis CCRI-1398 EU156877
 S. mitis CCRI-15034 EU156880
 CCRI-15020 EU156879S. mitis
TATCC 49456  EU156876S. mitis
 S. pseudopneumoniae CCUG 50868 EU 156902
 S. pneumoniae 101/87 GU326250
 CCRI-14955 EU156878S. mitis
 S. pneumoniae 1504 GU326251
 S. oralis CCRI-15017 EU156885
ATCC 10557 GU326248S. oralis
T ATCC 35037 EU156884S. oralis
 CCRI-15027 EU156886S. oralis
ATCC 9811S. oralis










T S. pneumoniae ATCC 33400  GU326222
ATCC 700675 EU156942S. pneumoniae
ATCC 51916 EU156906S. pneumoniae
ATCC 700673 EU156906S. pneumoniae
ATCC 700671 EU156940S. pneumoniae
 1504 EU156952S. pneumoniae
 S. pseudopneumoniae CCUG 50868 EU156957
 CCUG 50870 EU156959S. pseudopneumoniae
 CCUG 50869 EU156958S. pseudopneumoniae
T CCUG 49455  EU156956S. pseudopneumoniae
 S. pneumoniae 578 EU156947
 S. mitis CCRI-1398 EU156920
 CCRI-15034 AY582543S. mitis
 S. pneumoniae 101/87 GU326221
 CCRI-14955 EU156921S. mitis
TATCC 49456 AF276269S. mitis
 CCRI-15020 EU156922S. mitis
T S. oralis ATCC 35037 AF276270
ATCC 9811 EU156927S. oralis
ATCC 10557 AY582544S. oralis
 CCRI-15027 EU156930S. oralis
 CCRI-15017 EU156929S. oralis















 S. pseudopneumoniae CCUG 50870 EU156861
 CCUG 50869 EU156860S. pseudopneumoniae
S. pseudopneumoniae CCUG 50868 EU156859
T S. pseudopneumoniae CCUG 49455  EU156858
 S. pneumoniae 1504 GU326288
 101/87 GU326287S. pneumoniae
ATCC 51916 EU156843S. pneumoniae
ATCC 700675 EU156843S. pneumoniae
ATCC 700671 EU156847S. pneumoniae
ATCC 700673 EU156790S. pneumoniae
TATCC 33400  EU156842S. pneumoniae
 578 GU326289S. pneumoniae
 S. mitis CCRI-1398 EU156818
TATCC 49456  EU156817S. mitis
 CCRI-15034 EU156822S. mitis
 CCRI-14955 EU156819S. mitis
 CCRI-15020 EU156820S. mitis
 S. oralis CCRI-15017 EU156830
 CCRI-15027 EU156831S. oralis
ATCC 10557 EU156826S. oralis
TATCC 35037  EU156827S. oralis
ATCC 9811 EU156828S. oralis




















FIG. 1. Phylogenetic trees of type and reference strains based on sequences of four housekeeping genes: (a) 16S rRNA, (b) atpD, (c) tuf, and (d)
recA. The distance trees were constructed with the neighbour-joining method and Kimura’s two-parameter substitution model. The value on
each branch is the estimated conﬁdence limit (expressed as a percentage) for the position of the branch as determined by bootstrap analysis
(1000 random resamplings). Only values exceeding 50% are shown. Streptococcus parasanguinis was used as outgroup. The scale bar represents a
percentage evolutionary distance. T indicates species type strains.
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 S. pseudopneumoniae CCUG 50869 EU156860
 S. pseudopneumoniae 2987-98 GU326296
 S. pseudopneumoniae 2482-91 GU326293
 S. pseudopneumoniae 2497-91 GU326295
 S. pseudopneumoniae CCRI-18123 (formerly S. pneumoniae) GU326297
 S. pseudopneumoniae CCRI-14743 (formerly S. pneumoniae) EU156857
 S. pseudopneumoniae 2483-91 GU326294
T S. pseudopneumoniae CCUG 49455  EU156858
 S. pseudopneumoniae CCRI-8984 (formerly S. pneumoniae) EU156868
 S. pseudopneumoniae CCUG 50868 EU156859
 S. pseudopneumoniae CCUG 50870 EU 156861
S. pseudopneumoniae strains
 S. pneumoniae recA-13 allele (1) EU156850
 S. pneumoniae recA-21 allele (1) GU326288
 S. pneumoniae recA-20 allele (1) GU326287
 S. pneumoniae recA-10 allele (1) EU156856
 S. pneumoniae recA-5 allele (1) EU156846
 S. pneumoniae recA-8 allele (3) EU156854
S. pneumoniae atypical strains
 S. pneumoniae recA-16 allele (1) EU156855
 S. pneumoniae recA-14 allele (1) EU156851
T S. pneumoniae recA-4 allele (57, including ATCC 33400 ) EU156842
 S. pneumoniae recA-7 allele (6) EU156845
 S. pneumoniae recA-3 allele (30) EU156867
 S. pneumoniae recA-2 allele (53) EU156843
 S. pneumoniae recA-18 allele (3) GU326290
 S. pneumoniae recA-9 allele (18) EU156852
 S. pneumoniae recA-6 allele (7) EU 156848
 S. pneumoniae recA-1 allele (102) EU156790
 S. pneumoniae recA-19 allele (1) GU326292
 S. pneumoniae recA-11 allele (1) EU156853
 S. pneumoniae recA-12 allele (1) EU156844
 S. pneumoniae recA-17 allele (2) GU326291
S. pneumoniae typical strains
 S. pneumoniae recA-22 allele (1) GU326289
 S. pneumoniae recA-15 allele (1) EU156849
S. pneumoniae atypical strains
 S. mitis CCRI-17399 GU326275
 S. mitis CCRI-17373 GU326272
 S. mitis CCRI-14955 EU156819
 S.mitis CCRI-15087 GU326262
 S. mitis CCRI-15085 GU326261
 S. mitis CCRI-15057 GU326259
 S. mitis CCRI-14944 GU326257
 S. mitis CCRI-15023 EU156821
 S. mitis CCRI-17332 GU326268
T S. mitis ATCC 49456  EU156817
 S. mitis CCRI-17389 GU326274
 S. mitis CCRI-15425 GU326266
 S. mitis CCRI-17380 GU326273
 S. mitis CCRI-15088 GU326263
 S. mitis CCRI-15095 GU326264
 S. mitis CCRI-15138 GU326265
 S. mitis CCRI-15059 GU326260
 S. mitis CCRI-15034 EU156822
 S. mitis CCUG 31489 EU156823
 S. mitis CCRI-1398 EU156818
 S. mitis CCRI-17327 GU326267
 S. mitis CCRI-17367 GU326271
 S. mitis CCRI-15082 EU169576
 S. mitis CCRI-15019 GU326258
 S. mitis CCRI-15020 EU156820
 S. mitis CCRI-17351 GU326270
 S. mitis CCRI-17339 GU326269
S. mitis strains
 S. oralis ATCC 10557 EU156826
T S. oralis ATCC 35037  EU156827
 S. oralis ATCC 9811 EU156828
 S. oralis CCRI-14980 EU156829
 S. oralis CCRI-15070 GU326276
 S. oralis CCRI-15134 EU156834
 S. oralis CCRI-17664 GU326284
 S. oralis CCRI-17368 GU326282
 S. oralis CCUG 41672 EU156837
 S. oralis CCRI-15017 EU156830
 S. oralis CCRI-15049 EU156833
 S. oralis CCRI-17354 GU326279
 S. oralis CCRI-17660 GU326283
 S. oralis CCRI-17364 GU326281
 S. oralis CCRI-17349 GU326277
 S. oralis CCRI-15027 EU156831
 S. oralis CCRI-17997 GU326286
 S. oralis CCRI-17867 GU326285
 S. oralis CCRI-17358 GU326280
 S. oralis CCRI-17350 GU326278
S. oralis strains


































FIG. 2. (a) Nucleotide sequence signature of Streptococcus pseudopneumoniae species. Numbers above the sequence alignment indicate nucleotide
positions. (b) Phylogenetic tree of clinical isolates based on recA gene sequences. The distance tree was constructed with the neighbour-joining
method and Kimura’s two-parameter substitution model. The value on each branch is the estimated conﬁdence limit (expressed as a percentage)
for the position of the branch as determined by bootstrap analysis (1000 random resamplings). Only values exceeding 50% are shown. Streptococ-
cus parasanguinis was used as outgroup. The scale bar represents a 2% evolutionary distance. Genbank accession numbers are provided for each
allele of Streptococcus pneumoniae and for each strain of S. pseudopneumoniae, Streptococcus mitis, and Streptococcus oralis. Numbers in parenthesis
indicate total of strains per S. pneumoniae allele. T indicates species type strains.
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clear separation between S. pseudopneumoniae, atypical
S. pneumoniae, and S. mitis (Fig. 1b). This may reﬂect a com-
plex evolutionary picture for atpD gene. Balsalobre et al. [19]
showed that the optochin susceptibility of some isolates of
the mitis group was attributable to the acquisition of atpC,
atpA and part of atpB by horizontal gene transfer. Horizontal
gene transfer or other recombination events could have also
affected the ATP synthase operon in the atpD region, thus
blurring the evolutionary signal between S. pseudopneumoniae,
S. pneumoniae, and S. mitis.
In our previous study, sequence analysis of tuf from 28
streptococcal species (including S. pneumoniae, S. mitis, and
S. oralis) proved this gene to be suitable for phylogenetic
analysis of streptococci [15]. In the present study, S. pseudo-
pneumoniae was added to the analysis. The phylogenetic tree
(based on sequences covering a 787-bp segment of tuf)
revealed that the four S. pseudopneumoniae strains grouped
together (bootstrap value of 97%) and had identical nucleo-
tide sequences (including the type strain) (Fig. 1c). Conse-
quently, tuf sequence phylogeny appears to be suitable for
the identiﬁcation of S. pseudopneumoniae. Several studies
have demonstrated the usefulness of recA sequences for the
differentiation of species and subspecies within various bacte-
rial genera, such as mycobacteria, vibrios, and lactobacilli
[16,20–23]. Analysis of an 817-bp segment of recA showed
that sequences of S. pseudopneumoniae were highly con-
served. The recA-based tree showed that S. pseudopneumo-
niae strains clustered with a bootstrap value of 100% at the
node (Fig. 1d). Moreover, a multiple sequence alignment
revealed three nucleotide variations shared by all S. pseudo-
pneumoniae strains but not found in other members of the
mitis group (Fig. 2a). One of these nucleotide variations
resulted in an amino acid change (Thr275 ﬁ Ala) corre-
sponding to a unique protein signature common to all
S. pseudopneumoniae strains. Therefore, the recA sequences
could constitute a good tool for identiﬁcation of S. pseudo-
pneumoniae.
Distinction of clinical isolates by tuf and recA sequencing
In order to validate the use of tuf and recA sequences for
identiﬁcation of S. pseudopneumoniae, partial sequences of
these two genes were determined for 334 isolates of the
mitis group (see Table S1), and phylogenetic trees were con-
structed with the neighbour-joining method. In order to sim-
plify the phylogenetic trees, only sequences representing the
allelic variations of S. pneumoniae are shown (Fig. 2 and
Fig. S2).
First, sequences covering a 761-bp segment of tuf were
used for phylogenetic analysis (Fig. S2). All S. pseudopneumo-
niae strains clustered together, except for one strain (2987-
98), which clustered with the tuf-14 allele of S. pneumoniae
(represented by strains 578 and CCRI-14740). Within the
S. pseudopneumoniae group, all tuf sequences were 100%
identical. However, one S. pneumoniae isolate (CCRI-18123)
clustered with the S. pseudopneumoniae group (bootstrap
value of 84%). Furthermore, it was difﬁcult to assign several
isolates to a species (see the top of the tree in Fig. S1). To
clarify the species identiﬁcation of these strains, optochin
and bile solubility tests were performed, and the test results
were compared with those obtained for known S. pseudo-
pneumoniae, S. pneumoniae, S. mitis and S. oralis strains
(Table 1). All strains were correctly identiﬁed, except for
strains CCRI-8984, CCRI-14743, and CCRI-18123. In fact,
these three strains were bile-insoluble, resistant to optochin
when incubated in CO2, but susceptible to optochin when
incubated in air. Thus, optochin and bile solubility pheno-
types strongly suggest that strains CCRI-8984, CCRI-14743,
and CCRI-18123, initially identiﬁed as S. pneumoniae, are
indeed representatives of S. pseudopneumoniae. Conse-
quently, the tuf-based tree did not allow clear differentiation
of S. pseudopneumoniae strains from some atypical S. pneumo-
niae and S. mitis strains. Although the usefulness of tuf
sequences for the identiﬁcation of 28 streptococcal species
was previously described [15], distinguishing between
S. pseudopneumoniae and S. pneumoniae appears to be difﬁcult
with the use of tuf gene. In fact, the similarity in tuf
sequences between S. pseudopneumoniae and S. pneumoniae
ranged from 98.6% to 99.9%.
Second, a 756-bp segment of recA from the 334 strepto-
coccal isolates was analysed. S. pneumoniae and S. pseudo-
pneumoniae clustered together (bootstrap value of 88%)
(Fig. 2b). All S. pseudopneumoniae strains have highly con-
served sequences for recA gene. Furthermore, S. pseudopneu-
moniae strains CCRI-8984, CCRI-14743 and CCRI-18123,
initially identiﬁed as S. pneumoniae by phenotypic tests rou-
tinely used in clinical laboratories, shared 100% recA identity
with the S. pseudopneumoniae type strain. All S. pseudopneu-
moniae strains (including the three strains re-identiﬁed in this
study) grouped into a monophyletic subcluster with a 99%
bootstrap value at the node. Comparison of the recA
sequences from strains of S. pseudopneumoniae, S. pneumoniae,
S. mitis, and S. oralis revealed interspecies identities ranging
from 89.2% to 97.6%. Moreover, all S. pseudopneumoniae iso-
lates analysed in this study had the same three single-nucleo-
tide polymorphisms (including the Thr275 ﬁ Ala signature).
On the basis of these data, S. pseudopneumoniae could be
clearly distinguished from S. pneumoniae as well as from other
mitis group streptococci by recA sequence analysis.
The tuf and recA sequences analysed from the 334 strep-
tococcal isolates included sequences from 143 and 129
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S. pneumoniae strains isolated from lower respiratory tract
and blood specimens, respectively. Among these S. pneumo-
niae isolates, three of 143 from lower respiratory tract spec-
imens were re-identiﬁed as S. pseudopneumoniae, and none of
129 from blood specimens was identiﬁed as S. pseudopneumo-
niae, suggesting that S. pseudopneumoniae has a low invasive
capacity. This further supports previous studies showing the
presence of S. pseudopneumoniae in the lower respiratory
tract [2,4,7].
Real-time PCR assay
For development of the S. pseudopneumoniae real-time PCR
assay, primers were designed to speciﬁcally amplify both
S. pseudopneumoniae and S. pneumoniae. One speciﬁc locked
nucleic acid-Taqman probe was designed to speciﬁcally
detect S. pseudopneumoniae strains. The position of primers
and probe on the recA gene are shown in Fig. S2. The analyt-
ical speciﬁcity of the real-time PCR assay was evaluated with
1 ng of puriﬁed genomic DNA from 11 S. pseudopneumoniae
strains, 12 S. pneumoniae strains (including nine atypical pneu-
mococci), and four strains each of S. mitis and S. oralis (cor-
responding to different clusters on recA gene). The analytical
speciﬁcity of the assay was 100% for S. pseudopneumoniae. In
order to determine the detection limit of the real-time PCR
assay, serial dilutions of puriﬁed genomic DNA from four
S. pseudopneumoniae strains were tested. The assay showed
high sensitivity, with a limit of detection equivalent to <10
genomic copies for S. pseudopneumoniae. Considering that all
S. pseudopneumoniae strains studied here were only isolated
from North America, more strains from other countries
need to be studied to better determine the ubiquity of our
real-time PCR. The development of a PCR assay for the spe-
ciﬁc identiﬁcation of S. pseudopneumoniae could contribute to
reﬁnement of the epidemiology of respiratory tract infec-
tions. Accurate identiﬁcation of S. pseudopneumoniae will help
to establish its prevalence in clinical settings.
Conclusion
This report describes a genetic target (recA) for the speciﬁc
identiﬁcation of S. pseudopneumoniae that allows good dis-
crimination of S. pseudopneumoniae from closely related spe-
cies. Moreover, in the present article, we describe for the
ﬁrst time the development and evaluation of a locked nucleic
acid-Taqman probe-based real-time PCR for the detection
and identiﬁcation of S. pseudopneumoniae. This real-time PCR
assay provides a rapid, speciﬁc, and sensitive method for the
identiﬁcation of S. pseudopneumoniae, thus rendering it feasi-
ble and attractive for diagnostic use or large-scale screening
to determine the prevalence of this species in respiratory
tract infections.
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